Singular Genomics (OMIC) PT Lowered to $2.25 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
Tweet
Share
E-mailGet Alerts OMIC Hot Sheet
Price: $20.01 --0%
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
UBS analyst John Sourbeer lowered the price target on Singular Genomics (NASDAQ: OMIC) to $2.25 (from $2.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Arista Networks (ANET) PT Raised to $240 at Truist Securities
- Henry Schein (HSIC) PT Raised to $95 at UBS
- Public Storage (PSA) PT Raised to $334 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
